Natera to Report Its Third Quarter 2024 Results on November 12, 2024
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Bernstein Maintains Outperform on Natera, Raises Price Target to $135
Loss-Making Natera, Inc. (NASDAQ:NTRA) Expected To Breakeven In The Medium-Term
Natera Shares Are Trading Higher After Canaccord Genuity Maintained a Buy Rating on the Stock and Raised Its Price Target From $145 to $150.
CCORF Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $150
